Exome Asset Management as of Sept. 30, 2024
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 59 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 6.3 | $9.3M | 10k | 885.94 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.4 | $6.5M | 44k | 149.31 | |
| Bridgebio Pharma (BBIO) | 3.6 | $5.4M | 211k | 25.46 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.6 | $5.3M | 120k | 43.89 | |
| Tg Therapeutics (TGTX) | 3.3 | $4.9M | 208k | 23.39 | |
| Align Technology (ALGN) | 3.2 | $4.8M | 19k | 254.32 | |
| Cigna Corp (CI) | 2.9 | $4.2M | 12k | 346.44 | |
| Gilead Sciences (GILD) | 2.8 | $4.2M | 50k | 83.84 | |
| Geron Corporation (GERN) | 2.8 | $4.1M | 905k | 4.54 | |
| Biontech Se Sponsored Ads (BNTX) | 2.8 | $4.1M | 35k | 118.77 | |
| Bristol Myers Squibb (BMY) | 2.7 | $4.0M | 78k | 51.74 | |
| Miragen Therapeutics (VRDN) | 2.7 | $4.0M | 174k | 22.75 | |
| Intuitive Surgical Com New (ISRG) | 2.5 | $3.6M | 7.4k | 491.27 | |
| Beigene Sponsored Adr | 2.3 | $3.4M | 15k | 224.51 | |
| Blueprint Medicines (BPMC) | 2.3 | $3.4M | 37k | 92.50 | |
| Glaukos (GKOS) | 2.3 | $3.4M | 26k | 130.28 | |
| Springworks Therapeutics (SWTX) | 2.2 | $3.2M | 101k | 32.04 | |
| Disc Medicine (IRON) | 2.1 | $3.2M | 65k | 49.14 | |
| Cytokinetics Com New (CYTK) | 2.1 | $3.1M | 59k | 52.80 | |
| Agios Pharmaceuticals (AGIO) | 2.0 | $2.9M | 66k | 44.43 | |
| Relay Therapeutics (RLAY) | 2.0 | $2.9M | 415k | 7.08 | |
| Apellis Pharmaceuticals (APLS) | 2.0 | $2.9M | 100k | 28.84 | |
| Dr Reddys Labs Adr (RDY) | 1.9 | $2.9M | 36k | 79.45 | |
| Natera (NTRA) | 1.9 | $2.9M | 23k | 126.95 | |
| Biogen Idec (BIIB) | 1.7 | $2.6M | 13k | 193.21 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $2.5M | 34k | 73.00 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.5 | $2.3M | 47k | 48.73 | |
| Mersana Therapeutics (MRSN) | 1.5 | $2.2M | 1.2M | 1.89 | |
| 89bio (ETNB) | 1.5 | $2.2M | 301k | 7.40 | |
| Akero Therapeutics (AKRO) | 1.5 | $2.2M | 77k | 28.69 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.5 | $2.2M | 138k | 15.99 | |
| Stoke Therapeutics (STOK) | 1.5 | $2.2M | 177k | 12.29 | |
| Amgen (AMGN) | 1.5 | $2.2M | 6.7k | 322.21 | |
| Guardant Health (GH) | 1.4 | $2.1M | 90k | 22.94 | |
| Nuvalent Inc-a (NUVL) | 1.4 | $2.0M | 20k | 102.30 | |
| Revance Therapeutics (RVNC) | 1.2 | $1.8M | 348k | 5.19 | |
| Kura Oncology (KURA) | 1.2 | $1.8M | 90k | 19.54 | |
| Rezolute Com New (RZLT) | 1.2 | $1.7M | 352k | 4.85 | |
| Pliant Therapeutics (PLRX) | 1.1 | $1.7M | 150k | 11.21 | |
| Edgewise Therapeutics (EWTX) | 1.1 | $1.6M | 60k | 26.69 | |
| Karyopharm Therapeutics Note 3.000%10/1 | 1.0 | $1.5M | 2.0M | 0.76 | |
| Staar Surgical Com Par $0.01 (STAA) | 1.0 | $1.5M | 41k | 37.15 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $1.5M | 46k | 32.89 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $1.5M | 197k | 7.60 | |
| Scholar Rock Hldg Corp (SRRK) | 0.8 | $1.1M | 133k | 8.38 | |
| Tectonic Therapeutic (TECX) | 0.7 | $1.1M | 36k | 30.30 | |
| Alvotech Ordinary Shares (ALVO) | 0.7 | $1.1M | 90k | 11.90 | |
| Quanterix Ord (QTRX) | 0.6 | $953k | 74k | 12.96 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $939k | 22k | 43.27 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.6 | $817k | 117k | 7.00 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $797k | 88k | 9.04 | |
| Vyne Therapeutics (VYNE) | 0.4 | $665k | 353k | 1.88 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.4 | $642k | 299k | 2.15 | |
| Adagene Ads (ADAG) | 0.4 | $583k | 263k | 2.22 | |
| Gossamer Bio (GOSS) | 0.3 | $462k | 469k | 0.99 | |
| Aprea Therapeutics Com New (APRE) | 0.3 | $377k | 137k | 2.75 | |
| Procaps Group Sa SHS (PROC) | 0.2 | $281k | 127k | 2.21 | |
| Leap Therapeutics Com New (LPTX) | 0.2 | $264k | 103k | 2.57 | |
| Pacific Biosciences of California (PACB) | 0.1 | $128k | 75k | 1.70 |
